跳至主要内容
临床试验/NCT03691701
NCT03691701已完成不适用

Pilot to Examine Risk and Feasibility of Remote Management of BP From Childhood Into Early Adulthood

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年7月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Achieved Blood Pressure

研究概览

简要总结

Hypertension is an increasingly common problem in children, especially among those who are obese or with diabetes and chronic kidney disease. This study is a pilot randomized controlled trial designed to test whether improved blood pressure control can be achieved with the use of remote home blood pressure monitoring in children with uncontrolled blood pressure.

详细描述

Hypertension is an increasingly common problem in children, especially among those who are obese or with diabetes and chronic kidney disease. This study is a pilot randomized controlled trial designed to test whether improved blood pressure control can be achieved with the use of remote home blood pressure monitoring in children with uncontrolled blood pressure. Study investigators will randomize 60 children who have elevated BP (defined as receipt of ≥1 anti-hypertensive agent or office SBP ≥90th percentile) to either home BP monitoring with a home SBP target of < 90th percentile or less than 120 mm Hg, which ever is lower (intervention group) versus usual care group in 2:1 ratio. This study aims to (1) compare the safety of BP lowering in intervention versus usual care patients, (2) determine the efficacy of the intervention and provide estimates for the refinement of sample size determination for an eventual full-scale trial, and (3) assess the feasibility and acceptability of the intervention, recruitment rates, and barriers to trial completion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
13 Years 至 30 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •must be receiving at least one anti-hypertensive agent or have an office SBP ≥120 mmHg or >90th percentile for age, sex or height at the time of the screening visit
  • •have a mid-arm circumference between 22-37cm (BP cuff size limitation)
  • •able to provide consent to participate in our study
  • •able to use smartphones, or able to use any phone to call or text our study personnel with home BP readings. If participant does not have a smartphone, they will be allowed to call, text, or e-mail home BP readings on a weekly basis instead.

排除标准

  • •We will exclude those who:
  • •are or are planning to become pregnant, due to inability to take multiple classes of anti-hypertensive agents
  • •are marginally housed, due to concerns regarding routine follow-up
  • •are actively participating in a different interventional trial that may affect blood pressure
  • •are unwilling to consent to participate
  • •institutionalized individuals or prisoners
  • •are actively abusing illicit drugs or alcohol
  • •have a history of poor or doubtful compliance (e.g., frequently missed appointments)
  • •have office SBP >170 mmHg
  • •are already taking ≥5 anti-hypertensive medications (any classes, including diuretics)
  • •have cognitive impairment prohibiting participation in the study

研究组 & 干预措施

Strict SBP Target

Experimental

Home SBP target < 120 mmHg or 90th percentile for age and height (whichever is lower)

干预措施: strict blood pressure control (Other)

Usual SBP Target

No Intervention

Usual care, no home SBP target

结局指标

主要结局

Achieved Blood Pressure

时间窗: Time Frame: Months 4-12

次要结局

  • Number of participants screened who enroll in trial(Months 0-12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验